中华放射医学与防护杂志
中華放射醫學與防護雜誌
중화방사의학여방호잡지
Chinese Journal of Radiological Medicine and Protection
2014年
2期
120-124
,共5页
王澜%韩春%祝淑钗%时高峰%王琦%党荣广%田华%孔洁%张安度
王瀾%韓春%祝淑釵%時高峰%王琦%黨榮廣%田華%孔潔%張安度
왕란%한춘%축숙차%시고봉%왕기%당영엄%전화%공길%장안도
食管肿瘤%放射疗法%磁共振弥散加权成像%表面弥散系数%疗效
食管腫瘤%放射療法%磁共振瀰散加權成像%錶麵瀰散繫數%療效
식관종류%방사요법%자공진미산가권성상%표면미산계수%료효
Esophageal neoplasms%Radiotherapy%Diffusion-weighted magnetic resonance imaging%Apparent diffusion coefficient%Therapeutic effect
目的 探讨磁共振弥散加权成像(DWI)在食管癌放疗疗效评价中的应用价值.方法 74例食管鳞癌患者接受三维适形放疗或调强放疗,处方剂量56 ~ 61.2 Gy,单次1.8 ~2 Gy.放疗前、放疗末及放疗后1~3个月行DWI检查,用食管钡餐造影、DWI高信号消失情况、表面弥散系数(ADC)对放疗疗效进行评价,并与预后相结合进行生存分析.结果 中位随访时间22个月,随访率98.7%.放疗末DWI高信号消失组23例,1、2年生存率分别为82.6%、68.5%;放疗后1~3个月消失组40例,1、2年生存率分别为74.5%、49.2%;始终未消失组11例,1年生存率9.1%,生存期最长17个月(x2=39.78,P<0.05).造影评价完全缓解47例中,20例放疗末DWI高信号消失;23例放疗后1~3个月消失,其1、2年生存率分别为80%、64.3%和86.7%、66.1%;高信号始终未消失4例,生存期4~7个月(x2=37.80,P<0.05).造影评价为部分缓解的26例中,3例放疗末高信号消失;17例放疗后1~3个月高信号消失,1、2年生存率为58.8%、19.3%、高信号始终未消失6例,生存期4 ~17个月(x2=11.72,P<0.05).患者正常食管组织的ADC0、食管肿瘤放疗前的ADC1及放疗末的ADC2值分别为(3.12±0.53)、(1.64±0.48)、(2.65±0.58) s/mm2,疗末ADC2/ADC0≤90%组(40例)与>90%组(34例)1、2年生存率分别为56.4%、28.2%和83.1%、75.7%(x2=10.35,P<0.05).放疗末肿瘤区域ADC值为独立预后影响因素(OR=0.060,P<0.05).结论 利用磁共振弥散加权成像检查对食管癌放疗疗效进行评价可以较好地提示预后,弥补食管钡餐造影在疗效评价中的不足,疗后肿瘤区域ADC值大小为独立预后影响因素.
目的 探討磁共振瀰散加權成像(DWI)在食管癌放療療效評價中的應用價值.方法 74例食管鱗癌患者接受三維適形放療或調彊放療,處方劑量56 ~ 61.2 Gy,單次1.8 ~2 Gy.放療前、放療末及放療後1~3箇月行DWI檢查,用食管鋇餐造影、DWI高信號消失情況、錶麵瀰散繫數(ADC)對放療療效進行評價,併與預後相結閤進行生存分析.結果 中位隨訪時間22箇月,隨訪率98.7%.放療末DWI高信號消失組23例,1、2年生存率分彆為82.6%、68.5%;放療後1~3箇月消失組40例,1、2年生存率分彆為74.5%、49.2%;始終未消失組11例,1年生存率9.1%,生存期最長17箇月(x2=39.78,P<0.05).造影評價完全緩解47例中,20例放療末DWI高信號消失;23例放療後1~3箇月消失,其1、2年生存率分彆為80%、64.3%和86.7%、66.1%;高信號始終未消失4例,生存期4~7箇月(x2=37.80,P<0.05).造影評價為部分緩解的26例中,3例放療末高信號消失;17例放療後1~3箇月高信號消失,1、2年生存率為58.8%、19.3%、高信號始終未消失6例,生存期4 ~17箇月(x2=11.72,P<0.05).患者正常食管組織的ADC0、食管腫瘤放療前的ADC1及放療末的ADC2值分彆為(3.12±0.53)、(1.64±0.48)、(2.65±0.58) s/mm2,療末ADC2/ADC0≤90%組(40例)與>90%組(34例)1、2年生存率分彆為56.4%、28.2%和83.1%、75.7%(x2=10.35,P<0.05).放療末腫瘤區域ADC值為獨立預後影響因素(OR=0.060,P<0.05).結論 利用磁共振瀰散加權成像檢查對食管癌放療療效進行評價可以較好地提示預後,瀰補食管鋇餐造影在療效評價中的不足,療後腫瘤區域ADC值大小為獨立預後影響因素.
목적 탐토자공진미산가권성상(DWI)재식관암방료료효평개중적응용개치.방법 74례식관린암환자접수삼유괄형방료혹조강방료,처방제량56 ~ 61.2 Gy,단차1.8 ~2 Gy.방료전、방료말급방료후1~3개월행DWI검사,용식관패찬조영、DWI고신호소실정황、표면미산계수(ADC)대방료료효진행평개,병여예후상결합진행생존분석.결과 중위수방시간22개월,수방솔98.7%.방료말DWI고신호소실조23례,1、2년생존솔분별위82.6%、68.5%;방료후1~3개월소실조40례,1、2년생존솔분별위74.5%、49.2%;시종미소실조11례,1년생존솔9.1%,생존기최장17개월(x2=39.78,P<0.05).조영평개완전완해47례중,20례방료말DWI고신호소실;23례방료후1~3개월소실,기1、2년생존솔분별위80%、64.3%화86.7%、66.1%;고신호시종미소실4례,생존기4~7개월(x2=37.80,P<0.05).조영평개위부분완해적26례중,3례방료말고신호소실;17례방료후1~3개월고신호소실,1、2년생존솔위58.8%、19.3%、고신호시종미소실6례,생존기4 ~17개월(x2=11.72,P<0.05).환자정상식관조직적ADC0、식관종류방료전적ADC1급방료말적ADC2치분별위(3.12±0.53)、(1.64±0.48)、(2.65±0.58) s/mm2,료말ADC2/ADC0≤90%조(40례)여>90%조(34례)1、2년생존솔분별위56.4%、28.2%화83.1%、75.7%(x2=10.35,P<0.05).방료말종류구역ADC치위독립예후영향인소(OR=0.060,P<0.05).결론 이용자공진미산가권성상검사대식관암방료료효진행평개가이교호지제시예후,미보식관패찬조영재료효평개중적불족,료후종류구역ADC치대소위독립예후영향인소.
Objective To investigate the application value of diffusion-weighted magnetic resonance imaging(DWI) in the evaluation of therapeutic effect of esophageal carcinoma treatment with 3-dimensional conformal radiotherapy(3D-CRT)or intensity-modulated radiation therapy (IMRT).Methods Seventy-four patients with advanced esophageal carcinoma received 3D-CRT or IMRT with the median dose of 60 Gy (56-61.2 Gy) given at conventional fractions,and followed up for a median follow-up time of 22 months.DWI was conducted before,at the end of,and 1-3 months after the radiotherapy.Therapeutic effect was evaluated by esophagography,status of hyperintense expression in DWI,and value of apparent diffusion coefficient (ADC).The prognosis analysis was performed associated with the above factors.Results Seventy-three patients were followed up with a follow-up rate of 98.7%.The hyperintense disappeared immediately after radiation in 23 of the 74 patients,disappeared 1-3 months after radiation in 40 patients,and never disappeared in 11 patients.The 1-,and 2-year survival rates of the immediate disappearance group were 82.6% and 68.5% respectively,and the 1-,and 2-year survival rates of the second and the third groups were 74.5%,42.9% and 9.1%.There was significant difference among the three groups (x2 =39.78,P < 0.05).Of the 47 patients who achieved complete remission according to esophagogram,hyperintense disappeared immediately after radiation in 20 patients,disappeared 1-3 months after radiation in 23 patients,and never disappeared in 4 patients.The 1-,and 2-year survival rates of the immediate disappearance group were 80% and 64.3% respectively,those of the disappearance 1-3 months later group were 86.7%,66.1% respectively,and the survival time of the non-disappearance group ranged from 4 to 7 months (x2 =37.80,P < 0.05).Of the 26 patients who achieved partial remission according to esophagogram,hyperintense disappeared immediately after radiotherapy in 3 patients who survived without tumor till the end of follow-up,disappeared 1-3 months after radiotherapy in 17 patients with the 1-,and 2-year survival rates of 58.8% and 19.3% respectively,and never disappeared in 6 patients who all died with the survival times of 4 to 17 months respectively (x2 =11.72,P < 0.05).The ADC values of the normal esophageal tissue (ADC0),esophageal tumor before radiotherapy (ADC1),and tumor tissue after radiotherapy(ADC2) were (3.12 ± 0.53),(1.64 ±0.48),and(2.65 ± 0.58),respectively.The 1-,and 2-year survival rates of the patients with the ADC2/ADC0 ≤90% (n =40) were 56.4% and 28.2% respectively,significantly lower than those with ADC2/ADC0 >90% (n =34) (83.1% and 75.7% respectively,x2 =10.35,both P < 0.05).Multivariate analysis of Cox regression showed that the ADC value of the tumor region after radiotherapy increased with the improvement of the prognosis for the normal esophageal tissue.Conclusions Examination of DWI can be used to evaluate the therapeutic effect of esophageal carcinoma treatment with 3D-CRT or IMRT accurately and make up the deficiency of esophagography.The ADC value of tumor region after radiotherapy can be an independent prognosis factor.